Shareholders’ Meeting approves all Board proposals

The Shareholders’ Meeting of Siegfried Holding AG today approved all proposals by the Board of Directors. It endorsed a higher distribution to the Shareholders of CHF 2.40 per share (2017: CHF 2.00). All members of the Board were reconfirmed. The proposals regarding remuneration of the members of the Board of Directors and of Management have been approved. 

» Media Release (PDF)

 

Siegfried’s 115th Annual Shareholders’ Meeting took place at the Zofingen City Hall and was attended by over 200 shareholders and proxies representing more than 50% of the shares. The Shareholders took the following decisions: 

  • The annual report, financial statements and consolidated financial statements for 2017 were approved; discharge was granted to the members of the Board of Directors. 
  • Appropriation of retained earnings to free reserves and increased payout to shareholders from capital contribution reserves of CHF 2.40 per entitled registered share was approved. 
  • Proposals concerning maximum remuneration of Board members until the 2019 Shareholders’ Meeting, fixed remuneration of Executive Management for the 2019 financial year, short-term performance-related remuneration for the 2017 financial year and long-term performance-related remuneration of Executive Management for the current financial year in the form of entitlements were approved. 
  • Colin Bond, Wolfram Carius, Andreas Casutt, Reto Garzetti, Ulla Schmidt and Martin Schmid were re-elected for a further term.
  • Andreas Casutt was re-elected as Chairman of Siegfried Holding AG. The separately elected Remuneration Committee consists of Reto Garzetti, Martin Schmid and Ulla Schmidt.
  • BDO AG, Aarau, was appointed as independent proxy representative and PwC, Basel, as auditors. 


Contact
Peter Gehler, Chief Communications Officer
peter.gehler@siegfried.ch
Tel. +41 62 746 11 48
Mobile +41 79 416 41 16

Siegfried Holding AG
Untere Bruehlstrasse 4
CH-4800 Zofingen
Tel. +41 62 746 11 11


About Siegfried

The Siegfried Group is active worldwide in the field of Life Sciences with production facilities located in Switzerland, the USA, Malta, China, Germany and France. At the end of 2017, Siegfried reported annual sales of CHF 751 million and employs at the time being approximately 2300 employees at nine locations on three continents. Siegfried Holding AG is listed on the Swiss Exchange (SIX: SFZN)

Siegfried is active in both the primary and secondary production of drugs. The company manufactures active pharmaceutical ingredients for the research-based pharmaceutical industry as well as the corresponding intermediates and controlled substances, and provides development and production services for finished dosage forms including sterile filling.

Contact:

Siegfried AG
Peter A. Gehler
Chief Communication Officer
Untere Bruehlstrasse 4
4800 Zofingen
Switzerland

Phone +41 62 746 1148
peter.gehler@siegfried.ch

to the top to top

Can't find the information
you are looking for?
Contact us

Siegfried AG
Untere Bruehlstrasse 4
CH-4800 Zofingen

Phone: +41 62 746 1111
Fax: +41 62 746 1202
info@siegfried.ch